Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 01 Mar 2024

Construction of an aerolysin-based multi-epitope vaccine against Aeromonas hydrophila: an in silico machine learning and artificial intelligence-supported approach

in Vaccines and Molecular Therapeutics

Abdullah S. Alawam
Maher S. Alwethaynani

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369890

4,893 views
9 citations

Review

Published on 01 Mar 2024

Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments

in Vaccines and Molecular Therapeutics

René Roy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1292588

3,844 views
1 citation

Brief Research Report

Published on 29 Feb 2024

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

in Vaccines and Molecular Therapeutics

Sofie Keijzer
Nienke Oskam
Pleuni Ooijevaar-de Heer
Maurice Steenhuis
Jim B.D. Keijser
Luuk Wieske
Koos P.J. van Dam
Eileen W. Stalman
Laura Y.L. Kummer
Laura Boekel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1314507

3,411 views

Review

Published on 29 Feb 2024

Approaches of dengue control: vaccine strategies and future aspects

in Vaccines and Molecular Therapeutics

Runa Akter
Faria Tasneem
Shuvo Das
Mahfuza Afroz Soma
Ilias Georgakopoulos-Soares
Rifat Tasnim Juthi
Saiful Arefeen Sazed

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362780

13,298 views
12 citations

Original Research

Published on 28 Feb 2024

Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus

in Vaccines and Molecular Therapeutics

Gabriela Mansano do Nascimento
Pablo Sebastian Britto de Oliveira
Salman Latif Butt
Diego G. Diel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1322879

3,188 views
4 citations

Original Research

Published on 28 Feb 2024

Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents

in Vaccines and Molecular Therapeutics

Oliver L. Sampson
Cecilia Jay
Emily Adland
Anna Csala
Nicholas Lim
Stella M. Ebbrecht
Lorna C. Gilligan
Angela E. Taylor
Sherley Sherafin George
Stephanie Longet

Frontiers in Immunology

doi 10.3389/fimmu.2024.1329805

2,808 views
2 citations

Editorial

Published on 27 Feb 2024

Editorial: Deciphering immunological mechanisms of spatial and temporal vaccine delivery

in Vaccines and Molecular Therapeutics

Mingzhao Zhu
Anna Katrina Walduck
Wei Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354796

1,151 views

Original Research

Published on 26 Feb 2024

Comprehensive evaluation of inactivated SARS-CoV-2 vaccination on sperm parameters and sex hormones

in Vaccines and Molecular Therapeutics

Yehao Dong
Zaihua Ba
Yining Qin
Jiao Ma
Yuqi Li
Yingze Zhang
Aijun Yang
Fei Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1321406

1,883 views

Review

Published on 26 Feb 2024

The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects

in Vaccines and Molecular Therapeutics

Craig P. Collins
Dan L. Longo
William J. Murphy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1345499

3,568 views
4 citations

Original Research

Published on 23 Feb 2024

Immunogenicity at delivery after Tdap vaccination in successive pregnancies

in Vaccines and Molecular Therapeutics

Louise De Weerdt
Anaïs Thiriard
Elke Leuridan
Arnaud Marchant
Kirsten Maertens

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360201

2,391 views
2 citations

Review

Published on 23 Feb 2024

Novel adjuvants in allergen-specific immunotherapy: where do we stand?

in Vaccines and Molecular Therapeutics

Yen-Ju Lin
Jennifer Zimmermann
Stefan Schülke

Frontiers in Immunology

doi 10.3389/fimmu.2024.1348305

20,396 views
16 citations

Original Research

Published on 22 Feb 2024

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

in Vaccines and Molecular Therapeutics

Hassen Kared
Ingrid Jyssum
Amin Alirezaylavasani
Ingrid M. Egner
Trung The Tran
Lisa Tietze
Katrine Persgård Lund
Anne Therese Tveter
Sella A. Provan
Hilde Ørbo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1296273

2,865 views
3 citations

Correction

Published on 21 Feb 2024

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

in Vaccines and Molecular Therapeutics

Lorenzo Federico
Brandon Malone
Simen Tennøe
Viktoriia Chaban
Julie Røkke Osen
Murat Gainullin
Eva Smorodina
Hassen Kared
Rahmad Akbar
Victor Greiff

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377041

1,102 views

Original Research

Published on 19 Feb 2024

Neisseria gonorrhoeae lipooligosaccharide glycan epitopes recognized by bactericidal IgG antibodies elicited by the meningococcal group B-directed vaccine, MenB-4C

in Vaccines and Molecular Therapeutics

Yih-Ling Tzeng
Soma Sannigrahi
Ray Borrow
David S. Stephens

Frontiers in Immunology

doi 10.3389/fimmu.2024.1350344

4,686 views
5 citations

Original Research

Published on 16 Feb 2024

D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant

in Vaccines and Molecular Therapeutics

Hyeong Won Kim
Mi-Kyeong Ko
So Hui Park
Seokwon Shin
Gang Sik Kim
Dong Yun Kwak
Jong-Hyeon Park
Su-Mi Kim
Jong-Soo Lee
Min Ja Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1330677

2,445 views
3 citations

Original Research

Published on 16 Feb 2024

Factors associated with foreign body infection in methicillin-resistant Staphylococcus aureus bacteremia

in Vaccines and Molecular Therapeutics

Kevin Bouiller
Natasia F. Jacko
Margot J. Shumaker
Brooke M. Talbot
Timothy D. Read
Michael Z. David

Frontiers in Immunology

doi 10.3389/fimmu.2024.1335867

1,698 views
2 citations